Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
- PMID: 15607965
- DOI: 10.1016/j.ccr.2004.11.012
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
Abstract
ONYX-015 is an adenovirus that lacks the E1B-55K gene product for p53 degradation. Thus, ONYX-015 was conceived as an oncolytic virus that would selectively replicate in p53-defective tumor cells. Here we show that loss of E1B-55K leads to the induction, but not the activation, of p53 in ONYX-015-infected primary cells. We use a novel adenovirus mutant, ONYX-053, to demonstrate that loss of E1B-55K-mediated late viral RNA export, rather than p53 degradation, restricts ONYX-015 replication in primary cells. In contrast, we show that tumor cells that support ONYX-015 replication provide the RNA export function of E1B-55K. These data reveal that tumor cells have altered mechanisms for RNA export and resolve the controversial role of p53 in governing ONYX-015 oncolytic selectivity.
Similar articles
-
Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy.Cancer Cell. 2005 Jul;8(1):61-74. doi: 10.1016/j.ccr.2005.06.009. Cancer Cell. 2005. PMID: 16023599
-
Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.J Virol. 2001 May;75(9):4297-307. doi: 10.1128/JVI.75.9.4297-4307.2001. J Virol. 2001. PMID: 11287579 Free PMC article.
-
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.J Virol. 1999 Jul;73(7):5333-44. doi: 10.1128/JVI.73.7.5333-5344.1999. J Virol. 1999. PMID: 10364280 Free PMC article.
-
Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.Semin Cancer Biol. 2000 Dec;10(6):453-9. doi: 10.1006/scbi.2000.0336. Semin Cancer Biol. 2000. PMID: 11170867 Review.
-
Genetically modified adenoviruses against gliomas: from bench to bedside.Neurology. 2004 Aug 10;63(3):418-26. doi: 10.1212/01.wnl.0000133302.15022.7f. Neurology. 2004. PMID: 15304571 Review.
Cited by
-
Oncolytic viruses: From bench to bedside with a focus on safety.Hum Vaccin Immunother. 2015;11(7):1573-84. doi: 10.1080/21645515.2015.1037058. Hum Vaccin Immunother. 2015. PMID: 25996182 Free PMC article. Review.
-
Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC.Front Oncol. 2019 Nov 8;9:1182. doi: 10.3389/fonc.2019.01182. eCollection 2019. Front Oncol. 2019. PMID: 31781493 Free PMC article. Review.
-
Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Viruses. 2010 Oct;2(10):2290-2355. doi: 10.3390/v2102290. Epub 2010 Oct 13. Viruses. 2010. PMID: 21994621 Free PMC article.
-
Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation.J Virol. 2009 May;83(9):4000-12. doi: 10.1128/JVI.02417-08. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211739 Free PMC article. Review. No abstract available.
-
HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.Mol Cancer. 2011 Nov 1;10:133. doi: 10.1186/1476-4598-10-133. Mol Cancer. 2011. PMID: 22040050 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous